Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression
Venkatesh Teja Banala, Sandeep Urandur, Shweta Sharma, et al.
Biomaterials Science (2019) Vol. 7, Iss. 7, pp. 2889-2906
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer
Jing Zhang, Ningning Wang, Qian Li, et al.
Chemical Communications (2021) Vol. 57, Iss. 18, pp. 2305-2308
Closed Access | Times Cited: 131
Smart nanomaterials for cancer diagnosis and treatment
Ragini Singh, Ayush Sharma, Joel Saji, et al.
Nano Convergence (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 93
Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy
Pratiksha Tiwari, Krishna Yadav, Ravi Prakash Shukla, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 290-348
Closed Access | Times Cited: 47
Exploring nanocarriers as innovative materials for advanced drug delivery strategies in onco-immunotherapies
Pratiksha Tiwari, Ravi Prakash Shukla, Krishna Yadav, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 128, pp. 108702-108702
Closed Access | Times Cited: 19
Recent advances in the redox-responsive drug delivery nanoplatforms: A chemical structure and physical property perspective
Shirin Mollazadeh, Marcin Maćkiewicz, Mostafa Yazdimamaghani
Materials Science and Engineering C (2020) Vol. 118, pp. 111536-111536
Closed Access | Times Cited: 116
Role of aldo‐keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential
Reza Khayami, Seyyed Reza Hashemi, Mohammad Amin Kerachian
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 16, pp. 8890-8902
Open Access | Times Cited: 79
Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer
Madhu Sharma, Avijit Kumar Bakshi, Naresh Mittapelly, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 43-70
Closed Access | Times Cited: 46
Self-Assembled Redox-Sensitive Polymeric Nanostructures Facilitate the Intracellular Delivery of Paclitaxel for Improved Breast Cancer Therapy
Shalini Gautam, Disha Marwaha, Neha Singh, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 4, pp. 1914-1932
Closed Access | Times Cited: 25
Intratumoral delivery of Mitomycin C using bio-responsive Gellan Gum Nanogel: In-vitro evaluation and enhanced chemotherapeutic efficacy
Nikhil Rai, Disha Marwaha, Shalini Gautam, et al.
International Journal of Biological Macromolecules (2025), pp. 140306-140306
Closed Access | Times Cited: 1
Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution
Peng Ji, Le Wang, Yi‐Wei Chen, et al.
Biomaterials Science (2019) Vol. 8, Iss. 1, pp. 462-472
Closed Access | Times Cited: 65
Extracellular vesicles-powered immunotherapy: Unleashing the potential for safer and more effective cancer treatment
Pratiksha Tiwari, Krishna Yadav, Ravi Prakash Shukla, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 756, pp. 110022-110022
Closed Access | Times Cited: 7
High‐nuclearity Luminescent Lanthanide Nanocages for Tumor Drug Delivery
Shi‐Qing Wang, Yili Wang, Xiaoping Yang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 12
Closed Access | Times Cited: 6
Co-delivery of chemotherapeutic drugs and cell cycle regulatory agents using nanocarriers for cancer therapy
Ying Sun, Hao Hu, Xiaodong Jing, et al.
Science China Materials (2021) Vol. 64, Iss. 8, pp. 1827-1848
Open Access | Times Cited: 36
Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer
Christian Bailly
European Journal of Pharmacology (2022) Vol. 931, pp. 175191-175191
Closed Access | Times Cited: 23
Synergistic delivery of Imatinib through multifunctional nano-crystalline capsules, in response to redox environment for improved breast cancer therapy
Disha Marwaha, Shalini Gautam, Neha Singh, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 226, pp. 113316-113316
Closed Access | Times Cited: 13
Theranostic lyotropic liquid crystalline nanostructures for selective breast cancer imaging and therapy
Sandeep Urandur, Venkatesh Teja Banala, Ravi Prakash Shukla, et al.
Acta Biomaterialia (2020) Vol. 113, pp. 522-540
Closed Access | Times Cited: 39
Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma
Ravi Prakash Shukla, Jayant Dewangan, Sandeep Urandur, et al.
Biomaterials Science (2019) Vol. 8, Iss. 5, pp. 1298-1315
Closed Access | Times Cited: 38
Recent Advances of D-α-tocopherol Polyethylene Glycol 1000 Succinate Based Stimuli-responsive Nanomedicine for Cancer Treatment
Guan Yang, Linyan Wang, Bo Wang, et al.
Current Medical Science (2020) Vol. 40, Iss. 2, pp. 218-231
Closed Access | Times Cited: 37
Ratiometric codelivery of Paclitaxel and Baicalein loaded nanoemulsion for enhancement of breast cancer treatment
Pavan Kumar Yadav, Ravi Saklani, Amrendra K. Tiwari, et al.
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123209-123209
Closed Access | Times Cited: 12
Alendronate-functionalized porous nano-crystalsomes mitigate osteolysis and consequent inhibition of tumor growth in a tibia-induced metastasis model
Ravi Prakash Shukla, Pratiksha Tiwari, Anirban Sardar, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 331-346
Closed Access | Times Cited: 4
Construction of Multifunctional Hyaluronic Acid Modified Gold Nanoparticles Clocked with Irinotecan and Indocyanine Green: Investigation of Chemotherapy and Cancer Cell Imaging
Soumya V. Menon, B.L. Juneja, Unnati Joshi, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106629-106629
Closed Access
YIGSR Functionalized Hybrid Exosomes Spatially Target Dasatinib to Laminin Receptors for Precision Therapy in Breast Cancer
Pratiksha Tiwari, Ravi Prakash Shukla, Krishna Yadav, et al.
Advanced Healthcare Materials (2025)
Open Access
Enhanced Apoptosis and Mitochondrial Cell Death by Paclitaxel-Loaded TPP-TPGS 1000 -Functionalized Nanoemulsion
Pavan Kumar Yadav, Ravi Saklani, Amrendra K Tiwari, et al.
Nanomedicine (2023) Vol. 18, Iss. 4, pp. 343-366
Closed Access | Times Cited: 10
AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis
Syamprasad NP, Siddhi Jain, Bishal Rajdev, et al.
Chemico-Biological Interactions (2023) Vol. 381, pp. 110566-110566
Closed Access | Times Cited: 10
Surface-Modified Lyotropic Crystalline Nanoconstructs Bearing Doxorubicin and Buparvaquone Target Sigma Receptors through pH-Sensitive Charge Conversion to Improve Breast Cancer Therapy
Neha Singh, Disha Marwaha, Shalini Gautam, et al.
Biomacromolecules (2023) Vol. 24, Iss. 12, pp. 5780-5796
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top